Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shandong Boan Biotechnology Company., Limited. Class H ( (HK:6955) ) has provided an announcement.
Shandong Boan Biotechnology Co., Ltd. has successfully completed the placement of 38,400,000 new shares, representing approximately 6.69% of the total issued shares, at a price of HK$10.42 per share. The placement raised approximately HK$395.60 million in net proceeds, which will be used for research and development, commercialization of products, and to replenish working capital.
More about Shandong Boan Biotechnology Company., Limited. Class H
Shandong Boan Biotechnology Co., Ltd. is a biotechnology company based in China. The company focuses on the research and development of innovative product candidates, including clinical trials for various antibodies and bispecific ADCs. It also engages in the commercialization of marketed and upcoming products.
Average Trading Volume: 12,906,288
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$7.6B
See more insights into 6955 stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money